CARL Stock Price, Chart, Stats & News

Carlsmed, Inc.
Save
Carlsmed, Inc. (CARL) does not currently pay a dividend.
293.60M
Market cap
–
Current P/E
–
Forward P/E
CARL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 75.31% |
Operating margin | -36.08% |
Pretax margin | -71.17% |
Net margin | -59.82% |
Effective tax rate | – |
ROA | -23.22% |
ROE | -263.64% |
D/E | 0.18x |
Interest coverage ratio | -10.20x |
CARL valuation
P/E | – |
P/S | 5.11x |
P/B | 1.39x |
P/CF | -4.74x |
P/FCF | -8.72x |
P/OCF | -4.74x |
PEG | 1.55x |
EV multiple | -9.64x |
About
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants.
Similar securities
Based on sector and market capitalization
Report issue










